DHCR7-DT and neoplasm: This inference was supported by two observations in the ICB-treated independent cohort, i.e., presence of ICB responders in subgroup (UB+ IFN1+ AP+), even if they had low TMB levels and the expression patterns of genes involved in tumor-T cell interactions (Figure 4A).